drug costs

PhRMA Files Suit Against Oregon's New Prescription Drug Pricing Laws

The drug company trade group PhRMA has filed a legal challenge to a pair of Oregon laws designed to curb prescription prices.

The Pharmaceutical Research and Manufacturers of America filed suit in Eugene against two bills that passed the Oregon Legislature with bipartisan support.

Tensions Mount In Legislature Over Bill Restricting Pharmacy Middlemen

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

SALEM – For six years, Oregon pharmacies have been lobbying the state Legislature to rein in fees imposed on them by pharmacy benefit managers, the third-party intermediaries that negotiate prices with drug manufacturers and prescription drug claims with insurers.

Hospitals Slashed Use Of Two Heart Drugs After Huge Price Hikes

Even before media reports and a congressional hearing vilified Valeant Pharmaceuticals International for raising prices on a pair of lifesaving heart drugs, Dr. Umesh Khot knew something was very wrong. Khot is a cardiologist at the Cleveland Clinic, which prides itself on outstanding heart care. The health system’s pharmacists had alerted doctors about the skyrocketing cost of the drugs, nitroprusside and isoproterenol. But these two older drugs, frequently used in emergency and intensive care situations, have no direct alternatives.

Getting a Handle on Pharmaceutical Costs

Oregon Health Forum explores this timely issue at its breakfast forum on November 2.

High cost specialty drugs have begun outpacing hospital expenditures, and public officials, lawmakers and consumer advocates are hard at work trying to figure out how to get a handle on this growing problem.


Subscribe to drug costs